Trade Becton Dickinson - BDX CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.56 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Becton Dickinson and Co ESG Risk Ratings
‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly
Prev. Close* | 246.35 |
Open* | 245.94 |
1-Year Change* | 1.5% |
Day's Range* | 245.47 - 248.22 |
52 wk Range | 228.62-287.32 |
Average Volume (10 days) | 1.59M |
Average Volume (3 months) | 34.42M |
Market Cap | 68.04B |
P/E Ratio | 45.89 |
Shares Outstanding | 289.54M |
Revenue | 19.37B |
EPS | 5.12 |
Dividend (Yield %) | 1.61702 |
Beta | 0.44 |
Next Earnings Date | Feb 1, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2024 | 247.09 | 2.88 | 1.18% | 244.21 | 248.32 | 244.21 |
Mar 27, 2024 | 246.35 | 4.87 | 2.02% | 241.48 | 246.45 | 241.48 |
Mar 26, 2024 | 241.79 | 0.38 | 0.16% | 241.41 | 242.68 | 240.31 |
Mar 25, 2024 | 241.46 | -2.52 | -1.03% | 243.98 | 244.39 | 240.08 |
Mar 22, 2024 | 246.08 | 4.08 | 1.69% | 242.00 | 246.60 | 241.61 |
Mar 21, 2024 | 241.51 | 5.07 | 2.14% | 236.44 | 241.85 | 236.39 |
Mar 20, 2024 | 237.68 | -1.01 | -0.42% | 238.69 | 239.80 | 235.75 |
Mar 19, 2024 | 240.18 | 1.92 | 0.81% | 238.26 | 240.24 | 237.35 |
Mar 18, 2024 | 237.55 | 1.89 | 0.80% | 235.66 | 239.29 | 235.66 |
Mar 15, 2024 | 236.67 | 3.08 | 1.32% | 233.59 | 237.66 | 233.45 |
Mar 14, 2024 | 237.08 | -1.09 | -0.46% | 238.17 | 238.69 | 234.95 |
Mar 13, 2024 | 238.68 | 1.69 | 0.71% | 236.99 | 241.16 | 236.12 |
Mar 12, 2024 | 237.62 | 0.58 | 0.24% | 237.04 | 238.79 | 236.94 |
Mar 11, 2024 | 239.29 | 0.78 | 0.33% | 238.51 | 241.89 | 237.85 |
Mar 8, 2024 | 239.78 | 2.83 | 1.19% | 236.95 | 241.20 | 235.33 |
Mar 7, 2024 | 237.45 | 1.70 | 0.72% | 235.75 | 238.60 | 235.75 |
Mar 6, 2024 | 235.47 | 2.36 | 1.01% | 233.11 | 236.50 | 232.91 |
Mar 5, 2024 | 233.35 | -2.95 | -1.25% | 236.30 | 238.32 | 233.03 |
Mar 4, 2024 | 235.50 | 1.94 | 0.83% | 233.56 | 236.35 | 233.05 |
Mar 1, 2024 | 235.12 | 1.47 | 0.63% | 233.65 | 236.15 | 232.46 |
Becton Dickinson Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, May 2, 2024 | ||
Time (UTC) 12:30 | Country US
| Event Q2 2024 Becton Dickinson and Co Earnings Release Q2 2024 Becton Dickinson and Co Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 18870 | 19131 | 16074 | 17290 | 15983 |
Revenue | 18870 | 19131 | 16074 | 17290 | 15983 |
Cost of Revenue, Total | 10267 | 10444 | 8934 | 9002 | 8714 |
Gross Profit | 8603 | 8687 | 7140 | 8288 | 7269 |
Total Operating Expense | 16579 | 17059 | 15170 | 15554 | 14490 |
Selling/General/Admin. Expenses, Total | 4709 | 4719 | 4185 | 4382 | 4146 |
Research & Development | 1256 | 1279 | 1039 | 1062 | 1004 |
Unusual Expense (Income) | 329 | 255 | 649 | 454 | 626 |
Operating Income | 2291 | 2072 | 904 | 1736 | 1493 |
Interest Income (Expense), Net Non-Operating | -491 | -373 | -501 | -626 | -359 |
Other, Net | -17 | -7 | 11 | 66 | 39 |
Net Income Before Taxes | 1783 | 1692 | 414 | 1176 | 1173 |
Net Income After Taxes | 1635 | 1604 | 352 | 1183 | 951 |
Net Income Before Extra. Items | 1635 | 1604 | 352 | 1183 | 951 |
Net Income | 1779 | 2092 | 874 | 1233 | 311 |
Total Adjustments to Net Income | -90 | -90 | -107 | -151 | -152 |
Income Available to Common Excl. Extra. Items | 1545 | 1514 | 245 | 1032 | 799 |
Income Available to Common Incl. Extra. Items | 1689 | 2002 | 767 | 1082 | 159 |
Dilution Adjustment | |||||
Diluted Net Income | 1689 | 2002 | 767 | 1082 | 159 |
Diluted Weighted Average Shares | 287.364 | 292.089 | 282.402 | 274.775 | 264.621 |
Diluted EPS Excluding Extraordinary Items | 5.37646 | 5.18335 | 0.86756 | 3.7558 | 3.01941 |
Dividends per Share - Common Stock Primary Issue | 3.48 | 3.32 | 3.16 | 3.08 | 3 |
Diluted Normalized EPS | 8.7972 | 8.60354 | 6.30307 | 6.54954 | 4.98943 |
Other Operating Expenses, Total | 18 | 362 | 363 | 654 | 0 |
Total Extraordinary Items | 144 | 488 | 522 | 50 | -640 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 4878 | 4821 | 4586 | 4761 | 4641 |
Revenue | 4878 | 4821 | 4586 | 4761 | 4641 |
Cost of Revenue, Total | 2778 | 2586 | 2453 | 2684 | 2574 |
Gross Profit | 2100 | 2235 | 2133 | 2077 | 2067 |
Total Operating Expense | 4329 | 4193 | 4001 | 4294 | 4106 |
Selling/General/Admin. Expenses, Total | 1190 | 1205 | 1187 | 1182 | 1149 |
Research & Development | 306 | 337 | 313 | 300 | 315 |
Unusual Expense (Income) | 70 | 65 | 50 | 106 | 68 |
Other Operating Expenses, Total | -15 | 0 | -2 | 22 | |
Operating Income | 549 | 628 | 585 | 467 | 535 |
Interest Income (Expense), Net Non-Operating | -95 | -108 | -96 | -38 | -98 |
Other, Net | 17 | 9 | -8 | -109 | -16 |
Net Income Before Taxes | 471 | 529 | 481 | 320 | 421 |
Net Income After Taxes | 407 | 461 | 509 | 287 | 390 |
Net Income Before Extra. Items | 407 | 461 | 509 | 287 | 390 |
Net Income | 407 | 461 | 509 | 287 | 360 |
Total Adjustments to Net Income | -15 | -23 | -23 | -22 | -22 |
Income Available to Common Excl. Extra. Items | 392 | 438 | 486 | 265 | 368 |
Income Available to Common Incl. Extra. Items | 392 | 438 | 486 | 265 | 338 |
Diluted Net Income | 392 | 438 | 486 | 265 | 338 |
Diluted Weighted Average Shares | 287.944 | 285.645 | 285.34 | 287.163 | 287.297 |
Diluted EPS Excluding Extraordinary Items | 1.36138 | 1.53337 | 1.70323 | 0.92282 | 1.2809 |
Dividends per Share - Common Stock Primary Issue | 0.91 | 0.91 | 0.91 | 0.87 | 0.87 |
Diluted Normalized EPS | 2.38241 | 2.13552 | 2.30953 | 1.55371 | 1.64526 |
Total Extraordinary Items | 0 | 0 | 0 | 0 | -30 |
- Annual
- Quarterly
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Total Current Assets | 8676 | 8141 | 8838 | 8969 | 6664 |
Cash and Short Term Investments | 1424 | 1014 | 2295 | 2845 | 566 |
Cash & Equivalents | 1416 | 1006 | 2283 | 2825 | 536 |
Short Term Investments | 8 | 8 | 12 | 20 | 30 |
Total Receivables, Net | 2534 | 2191 | 2497 | 2398 | 2345 |
Accounts Receivable - Trade, Net | 2534 | 2191 | 2497 | 2398 | 2345 |
Total Inventory | 3273 | 3224 | 2866 | 2743 | 2579 |
Prepaid Expenses | 1380 | 1559 | 1072 | 891 | 1119 |
Other Current Assets, Total | 65 | 153 | 108 | 92 | 55 |
Total Assets | 52780 | 52934 | 53866 | 54012 | 51765 |
Property/Plant/Equipment, Total - Net | 6557 | 6012 | 6393 | 5923 | 5659 |
Property/Plant/Equipment, Total - Gross | 13578 | 12415 | 12942 | 11919 | 11128 |
Accumulated Depreciation, Total | -7021 | -6402 | -6549 | -5996 | -5469 |
Goodwill, Net | 24522 | 24621 | 23901 | 23620 | 23376 |
Intangibles, Net | 10948 | 12310 | 12783 | 13813 | 14978 |
Other Long Term Assets, Total | 2077 | 1850 | 1951 | 1687 | 1088 |
Total Current Liabilities | 6641 | 7811 | 6626 | 5836 | 5655 |
Payable/Accrued | |||||
Notes Payable/Short Term Debt | 0 | 230 | 500 | 5 | 10 |
Current Port. of LT Debt/Capital Leases | 1141 | 1949 | 0 | 702 | 1299 |
Other Current Liabilities, Total | 140 | 157 | 176 | 143 | 140 |
Total Liabilities | 26984 | 27652 | 30189 | 30247 | 30684 |
Total Long Term Debt | 14738 | 13886 | 17110 | 17224 | 18081 |
Long Term Debt | 14738 | 13886 | 17110 | 17224 | 18081 |
Deferred Income Tax | 4582 | 5052 | 5225 | 5753 | 5676 |
Other Liabilities, Total | 1023 | 903 | 1228 | 1434 | 1272 |
Total Equity | 25796 | 25282 | 23677 | 23765 | 21081 |
Common Stock | 371 | 365 | 365 | 365 | 347 |
Additional Paid-In Capital | 19720 | 19553 | 19272 | 19270 | 16270 |
Retained Earnings (Accumulated Deficit) | 15535 | 15157 | 13826 | 12791 | 12913 |
Treasury Stock - Common | -8305 | -8330 | -7723 | -6138 | -6190 |
Other Equity, Total | -1525 | -1465 | -2065 | -2525 | -2261 |
Total Liabilities & Shareholders’ Equity | 52780 | 52934 | 53866 | 54012 | 51765 |
Total Common Shares Outstanding | 290.392 | 283.357 | 284.476 | 290.017 | 270.427 |
Accounts Payable | 1641 | 1699 | 1793 | 1355 | 1092 |
Accrued Expenses | 3719 | 3776 | 4157 | 3631 | 3114 |
Preferred Stock - Non Redeemable, Net | 0 | 2 | 2 | 2 | 2 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 8676 | 8588 | 9587 | 8175 | 8141 |
Cash and Short Term Investments | 1424 | 931 | 1987 | 612 | 1014 |
Cash & Equivalents | 1416 | 923 | 1981 | 612 | 1006 |
Short Term Investments | 8 | 8 | 6 | 0 | 8 |
Total Receivables, Net | 2534 | 2414 | 2413 | 2282 | 2191 |
Accounts Receivable - Trade, Net | 2534 | 2414 | 2413 | 2282 | 2191 |
Total Inventory | 3273 | 3588 | 3656 | 3604 | 3224 |
Prepaid Expenses | 1380 | 1282 | 1444 | 1545 | 1559 |
Other Current Assets, Total | 65 | 373 | 87 | 132 | 153 |
Total Assets | 52780 | 53017 | 54394 | 53129 | 52934 |
Property/Plant/Equipment, Total - Net | 6557 | 6474 | 6356 | 6247 | 6012 |
Property/Plant/Equipment, Total - Gross | 13578 | 13475 | 13204 | 12926 | 12415 |
Accumulated Depreciation, Total | -7021 | -7002 | -6848 | -6679 | -6402 |
Goodwill, Net | 24522 | 24584 | 24780 | 24763 | 24621 |
Intangibles, Net | 10948 | 11313 | 11677 | 11990 | 12310 |
Other Long Term Assets, Total | 2077 | 2058 | 1994 | 1954 | 1850 |
Total Current Liabilities | 6641 | 6878 | 7304 | 7625 | 7811 |
Payable/Accrued | 5021 | 5090 | 5437 | ||
Notes Payable/Short Term Debt | 0 | 279 | 595 | 595 | 0 |
Current Port. of LT Debt/Capital Leases | 1141 | 1577 | 1619 | 1593 | 2179 |
Total Liabilities | 26984 | 27080 | 28703 | 27657 | 27652 |
Total Long Term Debt | 14738 | 14926 | 16010 | 14268 | 13886 |
Long Term Debt | 14738 | 14926 | 16010 | 14268 | 13886 |
Deferred Income Tax | 4582 | 4373 | 4471 | 4862 | 5052 |
Other Liabilities, Total | 1023 | 903 | 918 | 902 | 903 |
Total Equity | 25796 | 25937 | 25691 | 25472 | 25282 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 2 | 2 | 2 |
Common Stock | 371 | 371 | 365 | 365 | 365 |
Additional Paid-In Capital | 19720 | 19681 | 19639 | 19590 | 19553 |
Retained Earnings (Accumulated Deficit) | 15535 | 15691 | 15563 | 15384 | 15157 |
Treasury Stock - Common | -8305 | -8321 | -8327 | -8333 | -8330 |
Other Equity, Total | -1525 | -1485 | -1551 | -1536 | -1465 |
Total Liabilities & Shareholders’ Equity | 52780 | 53017 | 54394 | 53129 | 52934 |
Total Common Shares Outstanding | 290.392 | 290.108 | 284.015 | 283.902 | 283.357 |
Accounts Payable | 1641 | 1699 | |||
Accrued Expenses | 3719 | 3776 | |||
Other Current Liabilities, Total | 140 | 1 | 157 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 1779 | 2092 | 874 | 1233 | 311 |
Cash From Operating Activities | 2634 | 4646 | 3539 | 3330 | 2865 |
Cash From Operating Activities | 2229 | 2230 | 2115 | 2253 | 1978 |
Deferred Taxes | -120 | -301 | -308 | -381 | -240 |
Non-Cash Items | 252 | 262 | 316 | -75 | 19 |
Cash Taxes Paid | 532 | 671 | 523 | 536 | 235 |
Cash Interest Paid | 390 | 474 | 515 | 658 | 674 |
Changes in Working Capital | -1506 | 363 | 542 | 300 | 797 |
Cash From Investing Activities | -3231 | -1880 | -1232 | -741 | -15733 |
Capital Expenditures | -973 | -1194 | -769 | -957 | -895 |
Other Investing Cash Flow Items, Total | -2258 | -686 | -463 | 216 | -14838 |
Cash From Financing Activities | -591 | -3306 | 22 | -3223 | -58 |
Financing Cash Flow Items | 1069 | -265 | -140 | -204 | -221 |
Total Cash Dividends Paid | -1082 | -1048 | -995 | -984 | -927 |
Issuance (Retirement) of Stock, Net | -500 | -1750 | 2917 | 0 | 0 |
Issuance (Retirement) of Debt, Net | -78 | -243 | -1760 | -2035 | 1090 |
Foreign Exchange Effects | -45 | 15 | -3 | -12 | -17 |
Net Change in Cash | -1233 | -525 | 2326 | -646 | -12943 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 969 | 509 | 1779 | 1491 | 1131 |
Cash From Operating Activities | 584 | 399 | 2634 | 1662 | 1118 |
Cash From Operating Activities | 1130 | 567 | 2229 | 1648 | 1094 |
Deferred Taxes | -325 | -118 | -120 | -99 | -53 |
Non-Cash Items | 145 | 89 | 252 | 192 | 259 |
Changes in Working Capital | -1335 | -648 | -1506 | -1570 | -1313 |
Cash From Investing Activities | -524 | -291 | -3231 | -1226 | -990 |
Capital Expenditures | -389 | -208 | -973 | -658 | -405 |
Other Investing Cash Flow Items, Total | -135 | -83 | -2258 | -568 | -585 |
Cash From Financing Activities | 835 | -534 | -591 | -42 | 804 |
Financing Cash Flow Items | -100 | -90 | 1069 | 1075 | 1347 |
Total Cash Dividends Paid | -563 | -281 | -1082 | -812 | -541 |
Issuance (Retirement) of Debt, Net | 1498 | -163 | -78 | -305 | -2 |
Foreign Exchange Effects | 14 | 11 | -45 | -26 | -4 |
Net Change in Cash | 909 | -415 | -1233 | 368 | 928 |
Issuance (Retirement) of Stock, Net | -500 | 0 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Becton Company profile
Becton Dickinson (BDX) is a US based healthcare safety and technologies company, founded in 1897. Operating via two business segments – BD Medical and BD Life Sciences – the company offers solutions for medical research, diagnosis, medication management, infection prevention, etc. Headquartered in Franklin Lakes, New Jersey, USA, Becton Dickinson has nearly 50,000 employees located across 50 countries. Since 1962, the company is listed on the New York Stock Exchange (NYSE), and is a component of the S&P 500. Discover the Becton Dickinson share price at Capitral.com.Industry: | Medical Equipment, Supplies & Distribution (NEC) |
One Becton Drive
FRANKLIN LAKES
NEW JERSEY 07417-1880
US
Income Statement
- Annual
- Quarterly
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com